399441 生物医药
已收盘 12-31 15:00:00
资讯
新帖
简况
*ST宁科（600165）股东湖南新合新生物医药有限公司质押1.78亿股，占总股本11.03%
证券之星 · 01-01 00:23
*ST宁科（600165）股东湖南新合新生物医药有限公司质押1.78亿股，占总股本11.03%
【新股IPO】景泽生物医药(合肥)股份有限公司向港交所主板提交上市申请
金吾财讯 · 12-31 23:25
【新股IPO】景泽生物医药(合肥)股份有限公司向港交所主板提交上市申请
位于大兴生物医药基地，首都医科大学新校区首栋钢结构建筑封顶
新京报 · 2025-12-29
位于大兴生物医药基地，首都医科大学新校区首栋钢结构建筑封顶
微光股份：离心风机EC风机终端可应用于半导体生物医药
证券之星 · 2025-12-29
微光股份：离心风机EC风机终端可应用于半导体生物医药
振东制药(300158.SZ)拟3000万元参与设立基金投资于生物医药领域
智通财经 · 2025-12-26
振东制药(300158.SZ)拟3000万元参与设立基金投资于生物医药领域
超研股份最新公告：拟共同投资设立基金重点投向新型储能、生物医药等领域
证券之星 · 2025-12-26
超研股份最新公告：拟共同投资设立基金重点投向新型储能、生物医药等领域
工信部：打造集成电路、新型显示、新材料、航空航天、低空经济、生物医药等新兴支柱产业
格隆汇APP · 2025-12-26
工信部：打造集成电路、新型显示、新材料、航空航天、低空经济、生物医药等新兴支柱产业
港股异动 | 派格生物医药-B(02565)涨超6% 近日接获基石投资者自愿延长禁售期通知
智通财经 · 2025-12-24
港股异动 | 派格生物医药-B(02565)涨超6% 近日接获基石投资者自愿延长禁售期通知
派格生物医药-B(02565)完成发行合共513.6万股配售股份
智通财经 · 2025-12-22
派格生物医药-B(02565)完成发行合共513.6万股配售股份
东阳光药(06887.HK)荣获"金格奖·年度卓越生物医药企业"奖项
中金财经 · 2025-12-22
东阳光药(06887.HK)荣获"金格奖·年度卓越生物医药企业"奖项
天保基建：以生物医药为主题发展方向
证券之星 · 2025-12-18
天保基建：以生物医药为主题发展方向
中国科学院院士陈润生：人工智能在生物医药、医学影像等领域展现出超凡实用价值
睿见Economy · 2025-12-16
中国科学院院士陈润生：人工智能在生物医药、医学影像等领域展现出超凡实用价值
康斯特：国际市场客户主要集中在石化、生物医药、电力以及计量检测等行业
证券之星 · 2025-12-15
康斯特：国际市场客户主要集中在石化、生物医药、电力以及计量检测等行业
12月15日上海莱士创60日新低，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 2025-12-15
12月15日上海莱士创60日新低，招商国证生物医药指数(LOF)C基金重仓该股
派格生物医药-B(02565.HK)：基石投资者作出第二次自愿延长禁售期
中金财经 · 2025-12-15
派格生物医药-B(02565.HK)：基石投资者作出第二次自愿延长禁售期
派格生物医药-B(02565)拟折让10%配售合共513.6万股配售股份 净筹约2.96亿港元
智通财经 · 2025-12-14
派格生物医药-B(02565)拟折让10%配售合共513.6万股配售股份 净筹约2.96亿港元
12月11日智飞生物创60日新低，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 2025-12-11
12月11日智飞生物创60日新低，招商国证生物医药指数(LOF)C基金重仓该股
安科生物姚建平：“AI+生物医药”大有可为
睿见Economy · 2025-12-11
安科生物姚建平：“AI+生物医药”大有可为
开放新高地 海南产业蜕变：生物医药领跑、南繁种业创新
21世纪经济报道 · 2025-12-11
开放新高地 海南产业蜕变：生物医药领跑、南繁种业创新
港股生物医药股表现活跃！歌礼制药-B涨超20%，圣诺医药-B涨超13%
老虎资讯综合 · 2025-12-09
港股生物医药股表现活跃！歌礼制药-B涨超20%，圣诺医药-B涨超13%
加载更多
公司概况
公司名称：
--
所属市场：
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"399441","market":"SZ","secType":"STK","nameCN":"生物医药","latestPrice":2145.94,"timestamp":1767164595000,"preClose":2152.55,"halted":0,"volume":244001454,"delay":0,"changeRate":-0.0031,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-6.61,"latestTime":"12-31 15:00:00","open":2153.07,"high":2165.67,"low":2142.33,"amount":9944000000,"amplitude":0.0108,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767576600000},"marketStatusCode":5,"adr":0,"adjPreClose":2152.55,"symbolType":"index","openAndCloseTimeList":[[1767144600000,1767151800000],[1767157200000,1767164400000]],"highLimit":0,"lowLimit":0,"ibTradeSell":false,"ibTradeBuySell":false,"isCdr":false,"pbRate":0,"marketValue":0,"turnoverRate":0,"status":1,"floatMarketCap":0},"requestUrl":"/m/hq/s/399441","defaultTab":"news","newsList":[{"id":"2600070314","title":"*ST宁科（600165）股东湖南新合新生物医药有限公司质押1.78亿股，占总股本11.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600070314","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600070314?lang=zh_cn&edition=full","pubTime":"2026-01-01 00:23","pubTimestamp":1767198199,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST宁科1月1日公开信息显示，股东湖南新合新生物医药有限公司向上海浦东发展银行股份有限公司长沙分行合计质押1.78亿股，占总股本11.03%。质押详情见下表：截止本公告日，股东湖南新合新生物医药有限公司已累计质押股份1.78亿股，占其持股总数的49.9%，股东上海中能企业发展(集团)有限公司已累计质押股份2.0亿股，占其持股总数的100.0%。*ST宁科主营业务：长链二元酸及煤质活性炭的生产销售业务及贸易业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010100000165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0077","600165","BK0229","161726","399441","BK0174","BK0070"],"gpt_icon":0},{"id":"2595770234","title":"【新股IPO】景泽生物医药(合肥)股份有限公司向港交所主板提交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2595770234","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595770234?lang=zh_cn&edition=full","pubTime":"2025-12-31 23:25","pubTimestamp":1767194712,"startTime":"0","endTime":"0","summary":"金吾财讯 | 据港交所12月31日披露，景泽生物医药 股份有限公司向港交所主板提交上市申请，中金公司、国元国际为其联席保荐人。公司是一家历史可追溯至2014年，专注于辅助生殖药物和眼科药物两大赛道的生物制药公司。财务方面，于2023年-2024年度及2025年截至6月30日止六个月，研发开支分别为1.22亿元、1.33亿元及82.9万元；对应同期，年内亏损及全面亏损总额分别为2.46亿元、2.43亿元及1.28亿元。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/NzQzNDA1NDU2OTQ1Mw==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NzQzNDA1NDU2OTQ1Mw==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1972433","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEXmain","161726","399441"],"gpt_icon":0},{"id":"2595738783","title":"位于大兴生物医药基地，首都医科大学新校区首栋钢结构建筑封顶","url":"https://stock-news.laohu8.com/highlight/detail?id=2595738783","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595738783?lang=zh_cn&edition=full","pubTime":"2025-12-29 20:50","pubTimestamp":1767012600,"startTime":"0","endTime":"0","summary":"新京报讯 12月29日，随着最后一根钢梁被稳稳吊起，首都医科大学新校区（校本部）项目首栋钢结构顺利封顶。首都医科大学新校区项目位于大兴新城生物医药基地北拓区东北角，步入施工现场，一栋栋钢结构建筑拔地而起。12月29日，首都医科大学新校区（校本部）项目部，封顶仪式现场。记者了解到，首都医科大学新校区（校本部）计划在2028年投用。","market":"hk","thumbnail":"https://media.bjnews.com.cn/image/2025/12/29/5669809235433696363.jpeg?x-oss-process=image/resize,m_lfit,w_365","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/image/2025/12/29/5669809235433696363.jpeg?x-oss-process=image/resize,m_lfit,w_365"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1767012029129345.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1767012029129345.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["399441","161726"],"gpt_icon":0},{"id":"2595868785","title":"微光股份：离心风机EC风机终端可应用于半导体生物医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2595868785","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595868785?lang=zh_cn&edition=full","pubTime":"2025-12-29 17:03","pubTimestamp":1766998997,"startTime":"0","endTime":"0","summary":"证券之星消息，微光股份(002801)12月29日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，我看到贵公司回答说离心风机、EC风机已应用于洁净室行业，目前销售占比公司总营收比重不高。这里提到的洁净室是为半导体行业提供有关的洁净室服务吗？微光股份回复：你好，公司离心风机、EC 风机配套于相关洁净室设备，终端可应用于半导体、生物医药等多个领域，受产业链分工及产品最终使用场景多样性影响，无法精准统计应用于半导体领域的具体营收情况。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900021867.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","159582","399441","BK0224","002801"],"gpt_icon":0},{"id":"2594329885","title":"振东制药(300158.SZ)拟3000万元参与设立基金投资于生物医药领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2594329885","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594329885?lang=zh_cn&edition=full","pubTime":"2025-12-26 17:47","pubTimestamp":1766742434,"startTime":"0","endTime":"0","summary":"智通财经APP讯，振东制药(300158.SZ)发布公告，为满足战略发展需求，充分借助专业投资机构的力量及资源优势，整合多方资源以获取长期投资回报、提升综合竞争力，在不影响公司日常经营和发展、有效控制投资风险的前提下，公司近日与海南隆门私募基金管理合伙企业(有限合伙)、温诺谣、北京新医咨询有限公司、上海维诺润诚医药科技有限公司共同签署了《温州隆门汇鑫三号创业投资合伙企业(有限合伙)合伙协议》。根据合伙协议约定，公司作为有限合伙人以自有资金认缴出资3000万元人民币，出资比例为28.5687%，以认缴出资额为限承担有限责任，主要投资于生物医药领域。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386056.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0186","399441","300158","BK0060","161726"],"gpt_icon":0},{"id":"2594260737","title":"超研股份最新公告：拟共同投资设立基金重点投向新型储能、生物医药等领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2594260737","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594260737?lang=zh_cn&edition=full","pubTime":"2025-12-26 17:44","pubTimestamp":1766742295,"startTime":"0","endTime":"0","summary":"超研股份(301602.SZ)公告称，公司拟与专业投资机构共同投资设立广东粤财中瀛新兴产业股权投资基金合伙企业（有限合伙），合伙企业拟募集资金人民币10亿元，其中公司作为有限合伙人，拟以自有资金认缴人民币5000万元，占比5%。基金重点投向新型储能、生物医药、智能终端产业链及相关领域企业。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600025683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","399441","301602","BK0251"],"gpt_icon":0},{"id":"2594266010","title":"工信部：打造集成电路、新型显示、新材料、航空航天、低空经济、生物医药等新兴支柱产业","url":"https://stock-news.laohu8.com/highlight/detail?id=2594266010","media":"格隆汇APP","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594266010?lang=zh_cn&edition=full","pubTime":"2025-12-26 13:36","pubTimestamp":1766727360,"startTime":"0","endTime":"0","summary":"格隆汇12月26日｜12月25日至26日，全国工业和信息化工作会议在京召开。会议强调，培育壮大新兴产业和未来产业。打造集成电路、新型显示、新材料、航空航天、低空经济、生物医药等新兴支柱产业。支持人工智能攻关。有序开展卫星物联网等新业务商用试验。创建首批国家新兴产业发展示范基地，建设一批创新型产业集群。开展未来产业重点细分赛道创新任务揭榜挂帅，完善具身智能、元宇宙等的创新发展政策。加强6G技术研发。 \n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2025-12-26/doc-inheawxv1039273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159703","159546","159227","399441","161726"],"gpt_icon":0},{"id":"2593423899","title":"港股异动 | 派格生物医药-B(02565)涨超6% 近日接获基石投资者自愿延长禁售期通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2593423899","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593423899?lang=zh_cn&edition=full","pubTime":"2025-12-24 11:05","pubTimestamp":1766545553,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，派格生物医药-B涨超6%，截至发稿，涨5.94%，报65.95港元，成交额508.22万港元。消息面上，派格生物医药-B发布公告，原禁售期的最后一天为2025年12月31日。截至本公告日期，基石投资者合共持有958.45万股H股，占公司已发行H股总数约3.43%。近日，公司接获基石投资者的通知，据此，基石投资者同意自原禁售期届满日期起至2026年4月30日不会以任何方式减持任何相关H股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385323.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02565","399441","BK1161","161726"],"gpt_icon":0},{"id":"2593808164","title":"派格生物医药-B(02565)完成发行合共513.6万股配售股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2593808164","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593808164?lang=zh_cn&edition=full","pubTime":"2025-12-22 20:59","pubTimestamp":1766408368,"startTime":"0","endTime":"0","summary":"智通财经APP讯，派格生物医药-B(02565)发布公告，配售协议的所有条件已获达成，配售已于2025年12月22日完成。根据配售协议的条款及条件，联席配售代理已以每股配售股份58.41港元的价格向不少于6名承配人配售合共513.6万股配售股份，相当于紧随配售完成后，经配发及发行配售股份扩大的H股的约1.81%及股份总数的约1.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384602.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161726","BK1161","399441","02565"],"gpt_icon":0},{"id":"2593485510","title":"东阳光药(06887.HK)荣获\"金格奖·年度卓越生物医药企业\"奖项","url":"https://stock-news.laohu8.com/highlight/detail?id=2593485510","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593485510?lang=zh_cn&edition=full","pubTime":"2025-12-22 17:37","pubTimestamp":1766396222,"startTime":"0","endTime":"0","summary":"12月22日，格隆汇在线上举办\"科技赋能·资本破局\"分享会。本次分享会，备受瞩目的卓越公司评选榜单将隆重揭晓，其中格隆汇\"金格奖\"年度卓越公司评选中，东阳光药荣获\"年度卓越生物医药企业\"奖项。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202512/22/20251222465579.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202512/22/20251222465579.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251222/31881523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["399441","161726","BK1191","06887"],"gpt_icon":0},{"id":"2592752619","title":"天保基建：以生物医药为主题发展方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2592752619","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592752619?lang=zh_cn&edition=full","pubTime":"2025-12-18 16:25","pubTimestamp":1766046338,"startTime":"0","endTime":"0","summary":"证券之星消息，天保基建(000965)12月18日在投资者关系平台上答复投资者关心的问题。投资者提问：近年来天津航空高端制造产业链井喷式发展，公司作为滨海城基建企业的龙头，未来会不会打造航空高端产业集聚产业园，以配合公司子公司航空产业的蓬勃发展，提高资产的质量？天保基建回复：您好，公司主题园区立足于天津自贸试验区、综合保税区多重资源优势和产业基础，以保税区“十四五”规划确立的主导产业发展方向为指引，确定了以生物医药为主题的发展方向。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800021617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0013","161726","000965","399441","BK0273","BK0172"],"gpt_icon":0},{"id":"2591677531","title":"中国科学院院士陈润生：人工智能在生物医药、医学影像等领域展现出超凡实用价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2591677531","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591677531?lang=zh_cn&edition=full","pubTime":"2025-12-16 11:51","pubTimestamp":1765857060,"startTime":"0","endTime":"0","summary":"专题：第十八届中国工业论坛\n 第十八届中国工业论坛于12月16日在北京举办，主题为“融合创新 工业当强”。中国科学院院士陈润生出席并演讲。\n 陈润生指出，人工智能本质是“脑”的数字孪生，以大模型为核心应用载体，凭借自然语言处理突破与多模态融合创新，在生物医药、医学影像等领域展现出超凡的实用价值。当前，人工智能正引发科技领域深刻变革，持续关注与应用人工智能，将为我们的生产、生活带来重大效益。\n\n 新浪声明：所有会议实录均为现场速记整理，未经演讲者审阅，新浪网登载此文出于传递更多信息之目的，并不意味着赞同其观点或证实其描述。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：王翔","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/hy/hyjz/2025-12-16/doc-inhayftm3351938.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["399441","BK1189","02251","161631","161726"],"gpt_icon":0},{"id":"2591664822","title":"康斯特：国际市场客户主要集中在石化、生物医药、电力以及计量检测等行业","url":"https://stock-news.laohu8.com/highlight/detail?id=2591664822","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591664822?lang=zh_cn&edition=full","pubTime":"2025-12-15 19:12","pubTimestamp":1765797139,"startTime":"0","endTime":"0","summary":"证券之星消息，康斯特(300445)12月15日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问美国太空探索技术公司（SpaceX）是不是贵司的客户？公司为其提供哪些产品呢？康斯特回复：您好，非常感谢您的关注与支持。公司已能为全球产业用户提供高效的压力/温湿度/过程信号校准测试仪表设备，应用区域分布广泛且不依赖单一客户，国际市场客户主要集中在石化、生物医药、电力以及计量检测等行业，包括太空探索等行业客户订单金额较小，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500026124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0225","300445","BK0028","161726","399441"],"gpt_icon":0},{"id":"2591153066","title":"12月15日上海莱士创60日新低，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2591153066","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591153066?lang=zh_cn&edition=full","pubTime":"2025-12-15 15:37","pubTimestamp":1765784229,"startTime":"0","endTime":"0","summary":"证券之星消息，12月15日上海莱士创60日新低，收盘报6.34元，当日跌1.55%，换手率0.52%，成交量34.48万手，成交额2.2亿元。重仓上海莱士的前十大公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共12家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C目前规模为15.39亿元，最新净值0.4037，较上一交易日上涨0.45%，近一年下跌1.13%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500013020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161726","399441","BK0046","BK0028","002252","BK0196","BK0239","BK0188"],"gpt_icon":0},{"id":"2591660659","title":"派格生物医药-B(02565.HK)：基石投资者作出第二次自愿延长禁售期","url":"https://stock-news.laohu8.com/highlight/detail?id=2591660659","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591660659?lang=zh_cn&edition=full","pubTime":"2025-12-15 07:37","pubTimestamp":1765755421,"startTime":"0","endTime":"0","summary":"格隆汇12月15日丨派格生物医药-B(02565.HK)发布公告，近日，公司接获基石投资者的通知，据此，基石投资者同意自原禁售期(经第一次禁售延长予以延长)届满日期起至2026年4月30日不会以任何方式减持任何相关H股(“第二次禁售延长”)。公司认为，第二次禁售延长表明基石投资者基于公司对推进技术方面的研发能力及在重大临床里程碑方面取得的重大进展，对公司的未来前景充满信心。基石投资者亦将持续审阅公司业绩，且或会基于实时发展及所实现的里程碑，考虑进一步延长禁售期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251215/31864713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["161726","399441","02565","BK1161"],"gpt_icon":0},{"id":"2591663104","title":"派格生物医药-B(02565)拟折让10%配售合共513.6万股配售股份 净筹约2.96亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591663104","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591663104?lang=zh_cn&edition=full","pubTime":"2025-12-14 19:35","pubTimestamp":1765712100,"startTime":"0","endTime":"0","summary":"智通财经APP讯，派格生物医药-B 发布公告，于2025年12月12日，本公司与联席配售代理订立配售协议，据此，本公司已有条件同意透过联席配售代理按尽力基准以每股配售股份58.41港元的价格向不少于六名承配人配售合共513.6万股配售股份，该等配售股份将由本公司根据一般授权按配售协议所载条款及条件发行。假设所有配售股份获悉数配售，配售的估计所得款项总额及所得款项净额将分别为约3亿港元及约2.96亿港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381270.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161726","399441","BK1161","02565"],"gpt_icon":0},{"id":"2590600445","title":"12月11日智飞生物创60日新低，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2590600445","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590600445?lang=zh_cn&edition=full","pubTime":"2025-12-11 15:37","pubTimestamp":1765438643,"startTime":"0","endTime":"0","summary":"证券之星消息，12月11日智飞生物创60日新低，收盘报19.38元，当日跌2.22%，换手率0.99%，成交量13.98万手，成交额2.73亿元。重仓智飞生物的前十大公募基金请见下表：根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共15家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C目前规模为15.39亿元，最新净值0.4034，较上一交易日上涨0.52%，近一年下跌0.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100019607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0239","LU1064130708.USD","LU1328615791.USD","399441","LU1064131003.USD","BK0188","LU2580892789.USD","LU2580892862.HKD","161726","300122","LU2148510915.USD","BK0077","BK0046"],"gpt_icon":0},{"id":"2590955777","title":"安科生物姚建平：“AI+生物医药”大有可为","url":"https://stock-news.laohu8.com/highlight/detail?id=2590955777","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590955777?lang=zh_cn&edition=full","pubTime":"2025-12-11 09:39","pubTimestamp":1765417140,"startTime":"0","endTime":"0","summary":" “2025中国企业竞争力年会”于12月9日至10日在北京举行。安徽安科生物工程（集团）股份有限公司执行总裁姚建平在演讲中表示，“AI+生物医药”完全可以结合。姚建平透露，近期合肥多家量子领域龙头企业均主动与他对接，探讨“AI+生物医药”的合作可能，这充分说明跨领域融合已成为产业共识。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/hy/hyjz/2025-12-11/doc-inhakwan8050860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0060","BK0070","161726","BK0042","399441","300009"],"gpt_icon":0},{"id":"2590559597","title":"开放新高地 海南产业蜕变：生物医药领跑、南繁种业创新","url":"https://stock-news.laohu8.com/highlight/detail?id=2590559597","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590559597?lang=zh_cn&edition=full","pubTime":"2025-12-11 07:00","pubTimestamp":1765407600,"startTime":"0","endTime":"0","summary":"生物医药产业领跑 近年来，海南自贸港在政策引导下，不断扩大开放程度，产业集群迸发活力。生物医药产业是海南省战略性新兴产业，也是海口高新区的领跑产业。向种图强，向海突破 除了生物医药产业，南繁种业和深海科技也是海南的一块“金字招牌”。业内人士指出，崖州湾国家实验室首单数据知识产权的成功登记，填补了海南省在数据知识产权登记","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-12-11/doc-inhakmnt8493069.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-12-11/doc-inhakmnt8493069.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["399441","161726"],"gpt_icon":0},{"id":"1166068199","title":"港股生物医药股表现活跃！歌礼制药-B涨超20%，圣诺医药-B涨超13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166068199","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166068199?lang=zh_cn&edition=full","pubTime":"2025-12-09 10:02","pubTimestamp":1765245754,"startTime":"0","endTime":"0","summary":"12月9日，港股$生物(000504)$医药股表现活跃，$歌礼制药-B(01672)$涨超20%，$圣诺医药-B(02257)$涨超13%，$昭衍新药(06127)$涨超10%，$药明合联(02268)$涨超4%，$药明生物(02269)$、$药明康德(02359)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"eb673bcce88aebafcbc37fb491eb2df2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","399441","161726","BK1515","01672","BK1574","02257","BK1191","BK1161"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1767353168089,"stockEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":-0.0401},{"period":"3month","weight":-0.144},{"period":"6month","weight":0.0062},{"period":"1year","weight":0.0522},{"period":"ytd","weight":0.0522}],"compareEarnings":[{"period":"1week","weight":0.0071},{"period":"1month","weight":0.014},{"period":"3month","weight":0.0222},{"period":"6month","weight":0.143},{"period":"1year","weight":0.1841},{"period":"ytd","weight":0.1841}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物医药(399441)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物医药(399441)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物医药,399441,生物医药股票,生物医药股票老虎,生物医药股票老虎国际,生物医药行情,生物医药股票行情,生物医药股价,生物医药股市,生物医药股票价格,生物医药股票交易,生物医药股票购买,生物医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物医药(399441)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物医药(399441)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}